ArticleJCI insight2023

Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2.

Michael D Grant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.